Stress hyperglycemia: An essential survival response!

Critical Care Medicine

Volumn 41, Issue 6, 2013, Pages

  Marik, Paul E ^a   Bellomo, Rinaldo ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER; LACTIC ACID;

BONE MARROW; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HYPERGLYCEMIA; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LETTER; LEUKOCYTE; MACROPHAGE; MORTALITY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; STRESS HYPERGLYCEMIA; SURVIVAL;

CRITICAL CARE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PRACTICE GUIDELINES AS TOPIC;

EID: 84878577167     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318283d124     Document Type: Letter

References (15)

1. Wiener RS, Wiener DC, Larson RJ: Benefts and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300:933-944
2. Kansagara D, Fu R, Freeman M, et al: Intensive insulin therapy in hospitalized patients: A systematic review. Ann Intern Med 2011; 154:268-282
3. Murad MH, Coburn JA, Coto-Yglesias F, et al: Glycemic control in non-critically ill hospitalized patients: A systematic review and meta-analysis. J Clin Endocrinol Metab 2012; 97:49-58
4. Marik PE, Preiser JC: Toward understanding tight glycemic control in the ICU: A systematic review and metaanalysis. Chest 2010; 137:544-551
5. Gandhi GY, Murad MH, Flynn DN, et al: Effect of perioperative insulin infusion on surgical morbidity and mortality: Systematic review and meta-analysis of randomized trials.7. Mayo Clin Proc 2008; 83:418-430
6. Griesdale DE, de Souza RJ, van Dam RM, et al: Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821-827
7. Intensive versus conventional glucose control in critically ill patients: The NICE-Sugar Study Investigators. N Engl J Med 2009; 360:1283-1297
8. Treggiari MM, Karir V, Yanez ND, et al: Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008; 12:R29
9. Green JP, Berger T, Garg N, et al: Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis. Acad Emerg Med 2012; 19:1268-1275
10. McNamara JJ, Mills D, Aaby GV: Effect of hypertonic glucose on hem-orrhagic shock in rabbits. Ann Thorac Surg 1970; 9:116-121
11. Mészáros K, Lang CH, Bagby GJ, et al: In vivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FAS E B J 1988; 2:3083-3086
12. Malftano C, Alba Loureiro TC, Rodrigues B, et al: Hyperglycaemia protects the heart after myocardial infarction: Aspects of programmed cell survival and cell death. Eur J Heart Fail 2010; 12:659-667
13. Ma G, Al-Shabrawey M, Johnson JA, et al: Protection against myo-cardial ischemia/reperfusion injury by short-term diabetes: Enhancement of VEGF formation, capillary density, and activation of cell survival signaling. Naunyn Schmiedebergs Arch Pharmacol 2006; 373:415-427
14. Tosaki A, Engelman DT, Engelman RM, et al: Diabetes and ATP-sen-sitive potassium channel openers and blockers in isolated ischemic/reperfused hearts. J Pharmacol Exp Ther 1995; 275:1115-1123
15. Jacobi J, Bircher N, Krinsley J, et al: Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40:3251-3276